The Experts below are selected from a list of 22320 Experts worldwide ranked by ideXlab platform
Robert S Mcduffie - One of the best experts on this subject based on the ideXlab platform.
-
intrauterine balloon tamponade in the management of Postpartum Hemorrhage
American Journal of Perinatology, 2007Co-Authors: Victor G Dabelea, Peter M Schultze, Robert S McduffieAbstract:This article reviews our experience with the use of intrauterine tamponade with balloon catheters in the management of severe Postpartum Hemorrhage. This is a case series report of 23 patients with Postpartum Hemorrhage unresponsive to medical therapy managed with intrauterine balloon tamponade. We identified these patients by International Classification of Diseases (ICD-9) codes and by reviewing labor and delivery logs. Balloon tamponade was attempted in 23 patients. When properly placed, catheters controlled Postpartum Hemorrhage in 18 of 20 cases (90%). In two cases, hysterectomy was required despite successful placement of the catheter. For Hemorrhage due to uterine atony, our success rate was 100% (11/11 cases). In three cases, technical difficulties led to placement failure. For bleeding due to retained placenta, our success rate was 80% (4/5; failure with placenta percreta). Vaginal bleeding was stopped with the catheter in two of three cases of amniotic fluid embolus and in one case after dilation and curettage for Postpartum septic shock. Thus balloon tamponade is an effective adjunct in the treatment of severe Postpartum Hemorrhage, especially when due to uterine atony when medical therapy fails.
K S Joseph - One of the best experts on this subject based on the ideXlab platform.
-
contribution of placenta accreta to the incidence of Postpartum Hemorrhage and severe Postpartum Hemorrhage
Obstetrics & Gynecology, 2015Co-Authors: Azar Mehrabadi, Sharon Bartholomew, Jennifer A Hutcheon, Michael S Kramer, Robert M Liston, K S JosephAbstract:OBJECTIVE:To quantify the contribution of placenta accreta to the rate of Postpartum Hemorrhage and severe Postpartum Hemorrhage.METHODS:All hospital deliveries in Canada (excluding Quebec) for the years 2009 and 2010 (N=570,637) were included in a retrospective cohort study using data from the Cana
-
temporal trends in Postpartum Hemorrhage and severe Postpartum Hemorrhage in canada from 2003 to 2010
Journal of obstetrics and gynaecology Canada, 2014Co-Authors: Azar Mehrabadi, Sharon Bartholomew, Jennifer A Hutcheon, Michael S Kramer, Robert M Liston, K S JosephAbstract:Abstract Objective Increases in Postpartum Hemorrhage have been reported from several countries. We assessed temporal trends in Postpartum Hemorrhage and severe Postpartum Hemorrhage in Canada between 2003 and 2010. Methods We carried out a population-based cohort study of all hospital deliveries in Canada (excluding Quebec) from 2003 to 2010 (n=2 193 425), using data from the Canadian Institute for Health Information. Postpartum Hemorrhage was defined as a blood loss of ≥ 500mL following vaginal delivery or ≥ 1000mL following Caesarean section, or as noted by the care provider. Severe Postpartum Hemorrhage was defined as Postpartum Hemorrhage plus blood transfusion, hysterectomy, or other procedures to control bleeding (including uterine suturing or ligation/embolization of pelvic arteries). Temporal trends were assessed using the chi-square test for trend, relative risks, and logistic regression. Results Postpartum Hemorrhage increased by 22% (95% CI 20% to 25%) from 5.1% in 2003 to 6.2% in 2010 ( P P P P P Conclusion Rates of Postpartum Hemorrhage and severe Postpartum Hemorrhage continued to increase in Canada between 2003 and 2010.
-
trends in Postpartum Hemorrhage from 2000 to 2009 a population based study
BMC Pregnancy and Childbirth, 2012Co-Authors: Azar Mehrabadi, Jennifer A Hutcheon, Robert M Liston, K S JosephAbstract:Background Postpartum Hemorrhage, a major cause of maternal death and severe maternal morbidity, increased in frequency in Canada between 1991 and 2004. We carried out a study to describe the epidemiology of Postpartum Hemorrhage in British Columbia, Canada, between 2000 and 2009.
Emily S. Miller - One of the best experts on this subject based on the ideXlab platform.
-
The association between 17-hydroxyprogesterone caproate use and Postpartum Hemorrhage
American Journal of Obstetrics & Gynecology MFM, 2019Co-Authors: Emily S. Miller, Allie SakowiczAbstract:Objective To evaluate whether receipt of 17α-hydroxyprogesterone caproate within 7 days of delivery is associated with increased risk of Postpartum Hemorrhage. Study Design This was a retrospective cohort study of women who were receiving 17α-hydroxyprogesterone caproate for preterm birth prevention and delivered between 2010 and 2014. Women were dichotomized by whether a dose of 17α-hydroxyprogesterone caproate was administered within 7 days of delivery. Demographic and clinical characteristics were examined, including obstetric history and details of 17α-hydroxyprogesterone caproate receipt. Bivariable analyses were used to compare the frequency of Postpartum Hemorrhage in women stratified by 17α-hydroxyprogesterone caproate receipt within 7 days of delivery. Multivariable analysis was used to adjust for potential confounders. Results Of 221 women who met inclusion criteria, 93 (42%) received 17α-hydroxyprogesterone caproate within 7 days of delivery and 18 (7.8%) experienced a Postpartum Hemorrhage. No differences were observed in the frequency of Postpartum Hemorrhage between women who did and did not deliver within 7 days of 17α-hydroxyprogesterone caproate injection (9.7% vs 7.0%, P=.478). These findings persisted after adjusting for potential confounders (adjusted odds ratio for Postpartum Hemorrhage, 2.9; 95% confidence interval, 0.5–15.8). Conclusion Recent receipt of 17α-hydroxyprogesterone caproate for prevention of recurrent preterm birth is not associated with risk of Postpartum Hemorrhage.
-
the association between intrauterine balloon tamponade duration and Postpartum Hemorrhage outcomes
American Journal of Obstetrics and Gynecology, 2017Co-Authors: Brett D Einerson, Patrick Schneider, Ian C Fields, Emily S. MillerAbstract:Background Intrauterine balloon tamponade is an effective treatment for Postpartum Hemorrhage when first-line treatments fail. The optimal duration of intrauterine balloon tamponade for management of Postpartum Hemorrhage is unclear. Objective The objective of the study was to determine whether intrauterine balloon tamponade removal >12 hours of duration is associated with Postpartum Hemorrhage–related clinical outcomes. Study Design This was a retrospective cohort study of women with Postpartum Hemorrhage from 2007 through 2014 who underwent intrauterine balloon tamponade. We excluded failures of intrauterine balloon tamponade (intrauterine balloon expulsion with duration 12 hours. Examined Postpartum Hemorrhage–related clinical outcomes included estimated blood loss after intrauterine balloon tamponade placement, blood product transfusion, use of adjuvant measures to control Postpartum Hemorrhage after intrauterine balloon tamponade (either uterine artery embolization or hysterectomy), and maternal intensive care unit admission. Secondary outcomes examined included Postpartum fever and hospital length of stay. Multivariable logistic regression models were used to control for confounding variables. Results Of 274 eligible women, 206 (75%) underwent intrauterine balloon tamponade for >12 hours and 68 (25%) underwent intrauterine balloon tamponade for 2–12 hours. The median estimated blood loss after intrauterine balloon tamponade placement (190 vs 143 mL, P = .116) as well as the frequencies of blood product transfusion (62.1% vs 51.5%, P = .120), transfusion of ≥4 U of packed red blood cells (17.0% vs 14.7%, P = .659), uterine artery embolization (15.1% vs 16.2%, P = .823), hysterectomy (0.0% vs 1.5%, P = .248), and intensive care unit admission (8.7% vs 7.4%, P = .721), was not statistically different between the groups, and this lack of association persisted in multivariable regressions. Intrauterine balloon tamponade duration >12 hours was associated with a higher frequency of Postpartum fever (27% vs 15%, P = .047) and a longer mean hospital length of stay (3.7 vs 3.1 days, P = .002). After adjusting for variables that differed statistically between groups, the difference in length of stay associated with intrauterine balloon tamponade duration was no longer present, but the association between intrauterine balloon tamponade duration >12 hours and Postpartum fever persisted (odds ratio, 2.33, 95% confidence interval, 1.07–5.11). Including chorioamnionitis as an independent variable in a post hoc multivariable analysis diminished the association between intrauterine balloon tamponade >12 hours and Postpartum fever (adjusted odds ratio, 2.04, 95% confidence interval, 0.92–4.53). Conclusion There are no significant differences in Postpartum Hemorrhage–related outcomes associated with intrauterine balloon tamponade duration >12 hours compared with removal 2–12 hours. If ongoing Hemorrhage has abated, it is reasonable to consider the removal of an intrauterine balloon by 12 hours after its initial placement.
Victor G Dabelea - One of the best experts on this subject based on the ideXlab platform.
-
intrauterine balloon tamponade in the management of Postpartum Hemorrhage
American Journal of Perinatology, 2007Co-Authors: Victor G Dabelea, Peter M Schultze, Robert S McduffieAbstract:This article reviews our experience with the use of intrauterine tamponade with balloon catheters in the management of severe Postpartum Hemorrhage. This is a case series report of 23 patients with Postpartum Hemorrhage unresponsive to medical therapy managed with intrauterine balloon tamponade. We identified these patients by International Classification of Diseases (ICD-9) codes and by reviewing labor and delivery logs. Balloon tamponade was attempted in 23 patients. When properly placed, catheters controlled Postpartum Hemorrhage in 18 of 20 cases (90%). In two cases, hysterectomy was required despite successful placement of the catheter. For Hemorrhage due to uterine atony, our success rate was 100% (11/11 cases). In three cases, technical difficulties led to placement failure. For bleeding due to retained placenta, our success rate was 80% (4/5; failure with placenta percreta). Vaginal bleeding was stopped with the catheter in two of three cases of amniotic fluid embolus and in one case after dilation and curettage for Postpartum septic shock. Thus balloon tamponade is an effective adjunct in the treatment of severe Postpartum Hemorrhage, especially when due to uterine atony when medical therapy fails.
Azar Mehrabadi - One of the best experts on this subject based on the ideXlab platform.
-
contribution of placenta accreta to the incidence of Postpartum Hemorrhage and severe Postpartum Hemorrhage
Obstetrics & Gynecology, 2015Co-Authors: Azar Mehrabadi, Sharon Bartholomew, Jennifer A Hutcheon, Michael S Kramer, Robert M Liston, K S JosephAbstract:OBJECTIVE:To quantify the contribution of placenta accreta to the rate of Postpartum Hemorrhage and severe Postpartum Hemorrhage.METHODS:All hospital deliveries in Canada (excluding Quebec) for the years 2009 and 2010 (N=570,637) were included in a retrospective cohort study using data from the Cana
-
temporal trends in Postpartum Hemorrhage and severe Postpartum Hemorrhage in canada from 2003 to 2010
Journal of obstetrics and gynaecology Canada, 2014Co-Authors: Azar Mehrabadi, Sharon Bartholomew, Jennifer A Hutcheon, Michael S Kramer, Robert M Liston, K S JosephAbstract:Abstract Objective Increases in Postpartum Hemorrhage have been reported from several countries. We assessed temporal trends in Postpartum Hemorrhage and severe Postpartum Hemorrhage in Canada between 2003 and 2010. Methods We carried out a population-based cohort study of all hospital deliveries in Canada (excluding Quebec) from 2003 to 2010 (n=2 193 425), using data from the Canadian Institute for Health Information. Postpartum Hemorrhage was defined as a blood loss of ≥ 500mL following vaginal delivery or ≥ 1000mL following Caesarean section, or as noted by the care provider. Severe Postpartum Hemorrhage was defined as Postpartum Hemorrhage plus blood transfusion, hysterectomy, or other procedures to control bleeding (including uterine suturing or ligation/embolization of pelvic arteries). Temporal trends were assessed using the chi-square test for trend, relative risks, and logistic regression. Results Postpartum Hemorrhage increased by 22% (95% CI 20% to 25%) from 5.1% in 2003 to 6.2% in 2010 ( P P P P P Conclusion Rates of Postpartum Hemorrhage and severe Postpartum Hemorrhage continued to increase in Canada between 2003 and 2010.
-
trends in Postpartum Hemorrhage from 2000 to 2009 a population based study
BMC Pregnancy and Childbirth, 2012Co-Authors: Azar Mehrabadi, Jennifer A Hutcheon, Robert M Liston, K S JosephAbstract:Background Postpartum Hemorrhage, a major cause of maternal death and severe maternal morbidity, increased in frequency in Canada between 1991 and 2004. We carried out a study to describe the epidemiology of Postpartum Hemorrhage in British Columbia, Canada, between 2000 and 2009.
